annual FCF:
-$117.30M+$130.18M(+52.60%)Summary
- As of today (May 24, 2025), ARQT annual free cash flow is -$117.30 million, with the most recent change of +$130.18 million (+52.60%) on December 31, 2024.
- During the last 3 years, ARQT annual FCF has risen by +$58.32 million (+33.21%).
- ARQT annual FCF is now -3007.31% below its all-time high of -$3.77 million, reached on December 31, 2017.
Performance
ARQT Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$30.99M-$25.24M(-439.11%)Summary
- As of today (May 24, 2025), ARQT quarterly free cash flow is -$30.99 million, with the most recent change of -$25.24 million (-439.11%) on March 31, 2025.
- Over the past year, ARQT quarterly FCF has increased by +$615.00 thousand (+1.95%).
- ARQT quarterly FCF is now -439.11% below its all-time high of -$5.75 million, reached on December 31, 2024.
Performance
ARQT quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$116.69M+$615.00K(+0.52%)Summary
- As of today (May 24, 2025), ARQT TTM free cash flow is -$116.69 million, with the most recent change of +$615.00 thousand (+0.52%) on March 31, 2025.
- Over the past year, ARQT TTM FCF has increased by +$81.98 million (+41.26%).
- ARQT TTM FCF is now -1507.91% below its all-time high of -$7.26 million, reached on March 31, 2019.
Performance
ARQT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ARQT Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.6% | +1.9% | +41.3% |
| 3 y3 years | +33.2% | +45.7% | +37.3% |
| 5 y5 years | -172.0% | -47.2% | -105.0% |
ARQT Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.3% | -439.1% | +65.8% | at high | +62.2% |
| 5 y | 5-year | -172.0% | +58.3% | -439.1% | +65.8% | -105.0% | +62.2% |
| alltime | all time | -3007.3% | +58.3% | -439.1% | +65.8% | -1507.9% | +62.2% |
ARQT Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$30.99M(+439.1%) | -$116.69M(-0.5%) |
| Dec 2024 | -$117.30M(-52.6%) | -$5.75M(-83.5%) | -$117.30M(-30.1%) |
| Sep 2024 | - | -$34.83M(-22.8%) | -$167.80M(-5.2%) |
| Jun 2024 | - | -$45.12M(+42.8%) | -$177.02M(-10.9%) |
| Mar 2024 | - | -$31.60M(-43.8%) | -$198.66M(-19.7%) |
| Dec 2023 | -$247.49M(-11.9%) | -$56.25M(+27.7%) | -$247.49M(-5.7%) |
| Sep 2023 | - | -$44.05M(-34.0%) | -$262.42M(-15.1%) |
| Jun 2023 | - | -$66.76M(-17.0%) | -$309.03M(+1.5%) |
| Mar 2023 | - | -$80.43M(+13.0%) | -$304.32M(+8.3%) |
| Dec 2022 | -$281.00M(+60.0%) | -$71.19M(-21.5%) | -$281.00M(+7.3%) |
| Sep 2022 | - | -$90.65M(+46.1%) | -$261.78M(+23.4%) |
| Jun 2022 | - | -$62.06M(+8.7%) | -$212.15M(+14.1%) |
| Mar 2022 | - | -$57.10M(+9.9%) | -$185.96M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$175.62M(+54.9%) | -$51.97M(+26.7%) | -$175.62M(+12.3%) |
| Sep 2021 | - | -$41.02M(+14.3%) | -$156.38M(+4.8%) |
| Jun 2021 | - | -$35.87M(-23.3%) | -$149.16M(+7.3%) |
| Mar 2021 | - | -$46.76M(+42.9%) | -$139.06M(+22.7%) |
| Dec 2020 | -$113.35M(+162.8%) | -$32.72M(-3.2%) | -$113.35M(+16.3%) |
| Sep 2020 | - | -$33.80M(+31.1%) | -$97.49M(+31.0%) |
| Jun 2020 | - | -$25.78M(+22.5%) | -$74.42M(+30.7%) |
| Mar 2020 | - | -$21.05M(+24.8%) | -$56.92M(+32.0%) |
| Dec 2019 | -$43.13M(+206.2%) | -$16.86M(+57.2%) | -$43.13M(+64.2%) |
| Sep 2019 | - | -$10.73M(+29.5%) | -$26.27M(+69.0%) |
| Jun 2019 | - | -$8.29M(+14.2%) | -$15.54M(+114.2%) |
| Mar 2019 | - | -$7.26M | -$7.26M |
| Dec 2018 | -$14.09M(+273.1%) | - | - |
| Dec 2017 | -$3.77M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual FCF year-on-year change?
- What is Arcutis Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
- What is Arcutis Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM FCF year-on-year change?
What is Arcutis Biotherapeutics annual free cash flow?
The current annual FCF of ARQT is -$117.30M
What is the all time high annual FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual free cash flow is -$3.77M
What is Arcutis Biotherapeutics annual FCF year-on-year change?
Over the past year, ARQT annual free cash flow has changed by +$130.18M (+52.60%)
What is Arcutis Biotherapeutics quarterly free cash flow?
The current quarterly FCF of ARQT is -$30.99M
What is the all time high quarterly FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly free cash flow is -$5.75M
What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
Over the past year, ARQT quarterly free cash flow has changed by +$615.00K (+1.95%)
What is Arcutis Biotherapeutics TTM free cash flow?
The current TTM FCF of ARQT is -$116.69M
What is the all time high TTM FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM free cash flow is -$7.26M
What is Arcutis Biotherapeutics TTM FCF year-on-year change?
Over the past year, ARQT TTM free cash flow has changed by +$81.98M (+41.26%)